Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07681375 · ClinicalTrials.gov registry record · Phase 1
Evaluation of Basal Insulin Initialization and Titration in People With Type 2 Diabetes Wearing a Dexcom G6 Sensor
A Phase 1 study, sponsored by DexCom.
- Active
- Registry status
- Phase 1
- Development phase
- 45
- Enrollment target
NCT07681375 is a Phase 1 study that is active but no longer recruiting, run by DexCom. The registered enrollment target is 45 participants.
The verdict
NCT07681375, a Phase 1 study, is active but no longer recruiting, sponsored by DexCom.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 45 participants
- Enrollment target
Study Summary
To evaluate the feasibility of the DexBasal Study System
Interventions
- DRUG Basal insulin
- DEVICE Dexcom Continuous Glucose Monitoring (CGM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2023-04-11 |
| Est. Completion | 2027-01-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07681375
The ClinicalTrials.gov registry entry for NCT07681375 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DexCom, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Basal insulin is the first listed.
NCT07681375 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07681375 about?
NCT07681375 is a clinical study titled "Evaluation of Basal Insulin Initialization and Titration in People With Type 2 Diabetes Wearing a Dexcom G6 Sensor". To evaluate the feasibility of the DexBasal Study System
What is the current status of trial NCT07681375?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 45 participants. The study started on 2023-04-11. Estimated completion is 2027-01-15.
What interventions are being tested in trial NCT07681375?
The interventions under investigation include: Basal insulin (DRUG), Dexcom Continuous Glucose Monitoring (CGM) (DEVICE).
Who is sponsoring clinical trial NCT07681375?
This trial is sponsored by DexCom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.